Senior Vice President, Clinical Development

The Company is seeking a Senior Vice President of Clinical Development to lead clinical strategy and execution across oncology and rare disease programs. The role will shape program-level development plans, design and oversee early- and late-stage trials, and guide regulatory strategy and agency interactions. The successful candidate will lead and mentor clinical development teams while partnering across clinical operations, regulatory affairs, translational medicine, and biostatistics to advance trials and strengthen evidence generation. Responsibilities also include clinical safety oversight, portfolio and resource planning, external scientific representation, and support for business development and investor communications. The role will incorporate AI, machine learning, and real-world data into trial design and execution. Candidates should have at least 15 years of clinical development experience, including substantial work in oncology, rare disease, immunology, or precision medicine, and an MD or MD/PhD in a relevant biomedical discipline is strongly preferred. Required qualifications include experience leading Phase 1 and Phase 1/2 trials, IND filings, clinical development plans, and direct engagement with the FDA and other regulatory agencies. Applicants should bring a record of cross-functional leadership and team development, along with experience managing clinical timelines and budgets. Strong scientific expertise, communication skills, and the ability to balance strategic planning with hands-on execution are essential. Familiarity with AI-enabled drug development and investor-facing communications is also valued.